Eli Lilly

USA

Eli Lilly

Lilly Corporate Center

John C. Lechleiter, Ph.D. — Chairman, President, and Chief Executive Officer
Melissa S Barnes — Chief Ethics and Compliance Officer and Senior Vice President, Enterprise Risk Management
Enrique Conterno — Senior Vice President and President, Lilly Diabetes
Maria Crowe — President, Manufacturing Operations
Stephen F. Fry — Senior Vice President, Human Resources and Diversity
Michael J. Harrington — Senior Vice President and General Counsel
Jan M. Lundberg, Ph.D — Executive Vice President, Science and Technology, and President, Lilly Research Laboratories
Sue Mahony, Ph.D — Senior Vice President and President, Lilly Oncology
Bart Peterson — Senior Vice President, Corporate Affairs and Communications
Derica W. Rice — Executive Vice President, Global Services, and Chief Financial Officer
Dave Ricks — Senior Vice President and President, Lilly Bio-Medicines
Jeffrey Simmons — Senior Vice President and President, Elanco Animal Health
Jacques Tapiero — Senior Vice President and President, Emerging Markets
Fionnuala M. Walsh — Senior Vice President, Global Quality

Obstetrics & Gynaecology, Cardiology, Oncology, Endocrinology, Urology, Psychology

Production

Diabetic retinopathy, Menopause, Depression, Prostatitis, Schizophrenia, Blood cancer, Virilia cancer, Muliebria cancer, Breast cancer, Lung cancer, Intestine cancer, Gastric cancer, Body-type anomalies, Hypertensive disease

LLY

John C. Lechleiter, Ph.D. — Chairman
Ralph Alvarez
Katherine Baicker, Ph.D.
Sir Winfried Bischoff
Michael L. Eskew
J. Erik Fyrwald
Alfred G. Gilman, M.D., Ph.D.
R. David Hoover
Karen N. Horn, Ph.D.
William G. Kaelin, Jr., M.D.
Ellen R. Marram
Douglas R. Oberhelman
Franklyn G. Prendergast, M.D., Ph.D.
Kathi P. Seifert

87.5400

Other, Technologies, Pharmaceuticals, Chemistry